PubMed:32023682 / 849-1129
Annnotations
LitCovid-PAS-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
EnjuParser_T140 | 0-5 | IN | denotes | After |
EnjuParser_T141 | 6-9 | DT | denotes | the |
EnjuParser_T142 | 10-18 | NN | denotes | outbreak |
EnjuParser_T143 | 19-21 | IN | denotes | of |
EnjuParser_T144 | 22-26 | DT | denotes | this |
EnjuParser_T145 | 27-34 | NN | denotes | disease |
EnjuParser_T146 | 34-35 | -COMMA- | denotes | , |
EnjuParser_T147 | 36-43 | JJ | denotes | Chinese |
EnjuParser_T148 | 44-54 | NNS | denotes | scientists |
EnjuParser_T149 | 55-63 | VBD | denotes | invested |
EnjuParser_T150 | 64-65 | DT | denotes | a |
EnjuParser_T151 | 66-69 | NN | denotes | lot |
EnjuParser_T152 | 70-72 | IN | denotes | of |
EnjuParser_T153 | 73-79 | NN | denotes | energy |
EnjuParser_T154 | 80-82 | TO | denotes | to |
EnjuParser_T155 | 83-88 | VB | denotes | carry |
EnjuParser_T156 | 89-92 | RP | denotes | out |
EnjuParser_T157 | 93-101 | NN | denotes | research |
EnjuParser_T158 | 102-104 | IN | denotes | by |
EnjuParser_T159 | 105-115 | VBG | denotes | developing |
EnjuParser_T160 | 116-121 | JJ | denotes | rapid |
EnjuParser_T161 | 122-132 | JJ | denotes | diagnostic |
EnjuParser_T162 | 133-141 | NNS | denotes | reagents |
EnjuParser_T163 | 141-142 | -COMMA- | denotes | , |
EnjuParser_T164 | 143-154 | VBG | denotes | identifying |
EnjuParser_T165 | 155-158 | DT | denotes | the |
EnjuParser_T166 | 159-169 | NNS | denotes | characters |
EnjuParser_T167 | 170-172 | IN | denotes | of |
EnjuParser_T168 | 173-176 | DT | denotes | the |
EnjuParser_T169 | 177-185 | NN | denotes | pathogen |
EnjuParser_T170 | 185-186 | -COMMA- | denotes | , |
EnjuParser_T171 | 187-196 | VBG | denotes | screening |
EnjuParser_T172 | 197-200 | RP | denotes | out |
EnjuParser_T173 | 201-209 | JJ | denotes | clinical |
EnjuParser_T174 | 210-215 | NNS | denotes | drugs |
EnjuParser_T175 | 216-220 | WDT | denotes | that |
EnjuParser_T176 | 221-224 | MD | denotes | may |
EnjuParser_T177 | 225-232 | VB | denotes | inhibit |
EnjuParser_T178 | 233-236 | DT | denotes | the |
EnjuParser_T179 | 237-242 | NN | denotes | virus |
EnjuParser_T180 | 242-243 | -COMMA- | denotes | , |
EnjuParser_T181 | 244-247 | CC | denotes | and |
EnjuParser_T182 | 248-251 | VBP | denotes | are |
EnjuParser_T183 | 252-259 | RB | denotes | rapidly |
EnjuParser_T184 | 260-270 | VBG | denotes | developing |
EnjuParser_T185 | 271-279 | NNS | denotes | vaccines |
EnjuParser_R144 | EnjuParser_T181 | EnjuParser_T140 | arg1Of | and,After |
EnjuParser_R145 | EnjuParser_T142 | EnjuParser_T140 | arg2Of | outbreak,After |
EnjuParser_R146 | EnjuParser_T142 | EnjuParser_T141 | arg1Of | outbreak,the |
EnjuParser_R147 | EnjuParser_T142 | EnjuParser_T143 | arg1Of | outbreak,of |
EnjuParser_R148 | EnjuParser_T145 | EnjuParser_T143 | arg2Of | disease,of |
EnjuParser_R149 | EnjuParser_T145 | EnjuParser_T144 | arg1Of | disease,this |
EnjuParser_R150 | EnjuParser_T181 | EnjuParser_T146 | arg1Of | and,"," |
EnjuParser_R151 | EnjuParser_T148 | EnjuParser_T147 | arg1Of | scientists,Chinese |
EnjuParser_R152 | EnjuParser_T148 | EnjuParser_T149 | arg1Of | scientists,invested |
EnjuParser_R153 | EnjuParser_T151 | EnjuParser_T149 | arg2Of | lot,invested |
EnjuParser_R154 | EnjuParser_T151 | EnjuParser_T150 | arg1Of | lot,a |
EnjuParser_R155 | EnjuParser_T151 | EnjuParser_T152 | arg1Of | lot,of |
EnjuParser_R156 | EnjuParser_T153 | EnjuParser_T152 | arg2Of | energy,of |
EnjuParser_R157 | EnjuParser_T155 | EnjuParser_T154 | arg1Of | carry,to |
EnjuParser_R158 | EnjuParser_T149 | EnjuParser_T154 | modOf | invested,to |
EnjuParser_R159 | EnjuParser_T157 | EnjuParser_T155 | arg2Of | research,carry |
EnjuParser_R160 | EnjuParser_T155 | EnjuParser_T156 | arg1Of | carry,out |
EnjuParser_R161 | EnjuParser_T155 | EnjuParser_T158 | arg1Of | carry,by |
EnjuParser_R162 | EnjuParser_T159 | EnjuParser_T158 | arg2Of | developing,by |
EnjuParser_R163 | EnjuParser_T162 | EnjuParser_T159 | arg2Of | reagents,developing |
EnjuParser_R164 | EnjuParser_T162 | EnjuParser_T160 | arg1Of | reagents,rapid |
EnjuParser_R165 | EnjuParser_T162 | EnjuParser_T161 | arg1Of | reagents,diagnostic |
EnjuParser_R166 | EnjuParser_T149 | EnjuParser_T163 | arg1Of | invested,"," |
EnjuParser_R167 | EnjuParser_T166 | EnjuParser_T164 | arg2Of | characters,identifying |
EnjuParser_R168 | EnjuParser_T149 | EnjuParser_T164 | modOf | invested,identifying |
EnjuParser_R169 | EnjuParser_T166 | EnjuParser_T165 | arg1Of | characters,the |
EnjuParser_R170 | EnjuParser_T166 | EnjuParser_T167 | arg1Of | characters,of |
EnjuParser_R171 | EnjuParser_T169 | EnjuParser_T167 | arg2Of | pathogen,of |
EnjuParser_R172 | EnjuParser_T169 | EnjuParser_T168 | arg1Of | pathogen,the |
EnjuParser_R173 | EnjuParser_T149 | EnjuParser_T170 | arg1Of | invested,"," |
EnjuParser_R174 | EnjuParser_T148 | EnjuParser_T171 | arg1Of | scientists,screening |
EnjuParser_R175 | EnjuParser_T174 | EnjuParser_T171 | arg2Of | drugs,screening |
EnjuParser_R176 | EnjuParser_T149 | EnjuParser_T171 | modOf | invested,screening |
EnjuParser_R177 | EnjuParser_T171 | EnjuParser_T172 | arg1Of | screening,out |
EnjuParser_R178 | EnjuParser_T174 | EnjuParser_T173 | arg1Of | drugs,clinical |
EnjuParser_R179 | EnjuParser_T174 | EnjuParser_T175 | arg1Of | drugs,that |
EnjuParser_R180 | EnjuParser_T174 | EnjuParser_T176 | arg1Of | drugs,may |
EnjuParser_R181 | EnjuParser_T177 | EnjuParser_T176 | arg2Of | inhibit,may |
EnjuParser_R182 | EnjuParser_T174 | EnjuParser_T177 | arg1Of | drugs,inhibit |
EnjuParser_R183 | EnjuParser_T179 | EnjuParser_T177 | arg2Of | virus,inhibit |
EnjuParser_R184 | EnjuParser_T179 | EnjuParser_T178 | arg1Of | virus,the |
EnjuParser_R185 | EnjuParser_T181 | EnjuParser_T180 | arg1Of | and,"," |
EnjuParser_R186 | EnjuParser_T149 | EnjuParser_T181 | arg1Of | invested,and |
EnjuParser_R187 | EnjuParser_T184 | EnjuParser_T181 | arg2Of | developing,and |
EnjuParser_R188 | EnjuParser_T148 | EnjuParser_T182 | arg1Of | scientists,are |
EnjuParser_R189 | EnjuParser_T184 | EnjuParser_T182 | arg2Of | developing,are |
EnjuParser_R190 | EnjuParser_T184 | EnjuParser_T183 | arg1Of | developing,rapidly |
EnjuParser_R191 | EnjuParser_T148 | EnjuParser_T184 | arg1Of | scientists,developing |
EnjuParser_R192 | EnjuParser_T185 | EnjuParser_T184 | arg2Of | vaccines,developing |
LitCovid-ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 0-280 | DRI_Challenge | denotes | After the outbreak of this disease, Chinese scientists invested a lot of energy to carry out research by developing rapid diagnostic reagents, identifying the characters of the pathogen, screening out clinical drugs that may inhibit the virus, and are rapidly developing vaccines. |
LitCovid-OGER
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 133-141 | CHEBI:33893 | denotes | reagents |
T4 | 237-242 | GO:0019012 | denotes | virus |
T2 | 133-141 | SO:0000695 | denotes | reagents |
T3 | 248-251 | SO:0001853 | denotes | are |
LitCovid-sentences-v1
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T6 | 0-280 | Sentence | denotes | After the outbreak of this disease, Chinese scientists invested a lot of energy to carry out research by developing rapid diagnostic reagents, identifying the characters of the pathogen, screening out clinical drugs that may inhibit the virus, and are rapidly developing vaccines. |
LitCovid-TimeML
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
tok150 | 0-5 | IN | denotes | After |
tok151 | 6-9 | DT | denotes | the |
tok152 | 10-18 | NN | denotes | outbreak |
tok153 | 19-21 | IN | denotes | of |
tok154 | 22-26 | DT | denotes | this |
tok155 | 27-34 | NN | denotes | disease |
tok156 | 34-35 | , | denotes | , |
tok157 | 36-43 | JJ | denotes | Chinese |
tok158 | 44-54 | NNS | denotes | scientists |
tok159 | 55-63 | VBD | denotes | invested |
tok160 | 64-65 | DT | denotes | a |
tok161 | 66-69 | NN | denotes | lot |
tok162 | 70-72 | IN | denotes | of |
tok163 | 73-79 | NN | denotes | energy |
tok164 | 80-82 | TO | denotes | to |
tok165 | 83-88 | VB | denotes | carry |
tok166 | 89-92 | IN | denotes | out |
tok167 | 93-101 | NN | denotes | research |
tok168 | 102-104 | IN | denotes | by |
tok169 | 105-115 | VBG | denotes | developing |
tok170 | 116-121 | JJ | denotes | rapid |
tok171 | 122-132 | JJ | denotes | diagnostic |
tok172 | 133-141 | NNS | denotes | reagents |
tok173 | 141-142 | , | denotes | , |
tok174 | 143-154 | VBG | denotes | identifying |
tok175 | 155-158 | DT | denotes | the |
tok176 | 159-169 | NNS | denotes | characters |
tok177 | 170-172 | IN | denotes | of |
tok178 | 173-176 | DT | denotes | the |
tok179 | 177-185 | NN | denotes | pathogen |
tok180 | 185-186 | , | denotes | , |
tok181 | 187-196 | NN | denotes | screening |
tok182 | 197-200 | IN | denotes | out |
tok183 | 201-209 | JJ | denotes | clinical |
tok184 | 210-215 | NNS | denotes | drugs |
tok185 | 216-220 | WDT | denotes | that |
tok186 | 221-224 | MD | denotes | may |
tok187 | 225-232 | VB | denotes | inhibit |
tok188 | 233-236 | DT | denotes | the |
tok189 | 237-242 | NN | denotes | virus |
tok190 | 242-243 | , | denotes | , |
tok191 | 244-247 | CC | denotes | and |
tok192 | 248-251 | VBP | denotes | are |
tok193 | 252-259 | RB | denotes | rapidly |
tok194 | 260-270 | VBG | denotes | developing |
tok195 | 271-279 | NNS | denotes | vaccines |
tok196 | 279-280 | . | denotes | . |
lookup27 | 22-26 | time_modifier | denotes | this |
lookup28 | 36-43 | country_adj | denotes | Chinese |
lookup29 | 80-82 | country_code | denotes | to |
lookup30 | 102-104 | country_code | denotes | by |
event2 | 105-115 | OCCURRENCE | denotes | developing |
event5 | 143-154 | OCCURRENCE | denotes | identifying |
event7 | 83-88 | OCCURRENCE | denotes | carry |
event9 | 260-270 | OCCURRENCE | denotes | developing |
event10 | 55-63 | OCCURRENCE | denotes | invested |
event12 | 225-232 | OCCURRENCE | denotes | inhibit |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 64-65 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T6 | 237-242 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T2 | 133-141 | Chemical | denotes | reagents | http://purl.obolibrary.org/obo/CHEBI_33893 |
T3 | 210-215 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 0-280 | Sentence | denotes | After the outbreak of this disease, Chinese scientists invested a lot of energy to carry out research by developing rapid diagnostic reagents, identifying the characters of the pathogen, screening out clinical drugs that may inhibit the virus, and are rapidly developing vaccines. |